
- MHE December 2020
- Volume 30
- Issue 12
MA stargazing reveals a different story
All the Medicare Advantage trend lines seem like they are northward bound. Enrollment, the number of plans, the number of companies selling those plans — they’re all up. So Avalere Health’s report last month on the percentage of beneficiaries in highly rated plans stood out — and not in a good way.
All the Medicare Advantage trend lines seem like they are northward bound. Enrollment, the number of plans, the number of companies selling those plans — they’re all up. So Avalere Health’s report last month on the percentage of beneficiaries in highly rated plans stood out — and not in a good way.
CMS’ Star Rating program grades the quality of Medicare Advantage plans on a scale of 1 to 5 stars, with 5 being the highest quality.
Using data that the CMS made available in October, Avalere Health calculated that approximately 11.9% of the enrollees in Medicare Advantage plans that include drug coverage are in 5-star plans, which isn’t a big difference from the 11% of enrollees in 5-star plans last year.
But the consulting firm’s numbers show that the proportion of enrollees in 4.5-star plans dropped sharply, from 31.4% last year to 19.6% this year, and the proportion in 4-star plans dipped from 38.8% last year to 30.9% this year.
Articles in this issue
almost 5 years ago
MHE State of the Industry survey: Healthcare disparities and racismalmost 5 years ago
MHE State of the Industry survey: The shift to value-based carealmost 5 years ago
MHE State of the Industry survey: The pandemic’s effectsalmost 5 years ago
MHE State of the Industry survey: The COVID-19 vaccinealmost 5 years ago
MHE State of the Industry survey: COVID-19 ranks No.1almost 5 years ago
The Pandemic Opens a Window of Opportunity for Telehealthalmost 5 years ago
Medicare Advantage Enrollment Keeps Growingalmost 5 years ago
2020 drug approvals: not bad, consideringNewsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.